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Clouds of Unknowing
Presidential Address to the Ulster Medical Society, Thursday 9th October 2008. 
Howard Fee 
This  is  the  Coat  of 
Arms  of  the  College 
of  Anaesthetists  in 
Dublin  granted  to 
the  College  in  1999 
(fig  1).  In  central 
position, representing 
anaesthesia is a shield 
containing  poppy 
heads.  The  cloud 
above  represents 
the  downwards  drift 
to  unconsciousness 
with the healing hand 
of  the  physician  in 
attendance. The cloud 
might have another interpretation for there can hardly be a 
treatment in medicine which is so widely applied and yet 
so little understood. The supporters are unusual in heraldry 
taking the form of dolphins and these provide a link to one 
of the founders of this Society, James MacDonnell (fig 2a) 
whose family coat of arms also bears this heraldic symbol 
(fig 2b). 
As most of you will know James was a son of the Glens and 
the first of a family of doctors all of whom rose to distinction 
in different ways. His thesis entitled ‘On the Drowned’ is the 
first formal account of resuscitation methods, and perhaps 
he might have been attracted to emergency medicine or even 
anaesthesia, had he lived a generation later. As it happened, 
it  was  his  surgeon  son,  John,  who  administered  the  first 
anaesthetic to a patient in Ireland, at the Richmond Hospital 
in Dublin.
MacDonnell broke the news in a letter to the Medical Times 
on New Year’s Day 1847 (fig 3a, 3b). It was not just a New 
Year; it was indeed a New Dawn. The details of the case 
were these: An 18 year old girl from the Drogheda area, 
Mary Kane, had been carrying hawthorn branches when she 
tripped and a thorn punctured her elbow. Over some weeks 
this became septic to the point where it threatened her life and 
the only recourse was amputation. MacDonnell had obviously 
heard about the new discovery and must have thought that 
Mary Kane being a strong young country girl would be an 
ideal  subject.  One  or  two  days  before  administering  the 
ether, MacDonnell decided to ‘ascertain on myself’, as he 
put it, the effects of the vapour and was assisted in this by a 
Fig 1. Coat of Arms of the College of 
Anaesthetists
Fig 2. Bust (left) and coat of arms (right) of James MacDonnell 
Fig 3. Extracts from the Medical Times letter © The Ulster Medical Society, 2009.
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colleague, surgeon Alexander McDonnell. ‘I rendered myself 
unconscious for some seconds, five or six times’. On the day 
of surgery itself, it took more than one attempt to get it right 
and we can but imagine the scene and the sense of relief, when 
at the end, Mary Kane opened her eyes.  
Far from congratulating himself, MacDonnell concludes his 
letter with great humility, writing, ‘It offers in my opinion 
an occasion beyond measure more worthy for Te Deums in 
Christian Cathedrals…than all the victories that fire and sword 
have ever achieved’. Te Deum Laudamus indeed!
The synthesis of ether was first described in modern times by 
the German apothecary Valerius Cordus in 1540. He called 
it “sweet oil of vitriol”. Maybe it’s too far-fetched to imagine 
that this gave rise to the expression ‘Sweet Dreams’. Raymond 
Lully, a 13th Century alchemist almost certainly came across 
it before this and probably many others. The basic ingredients 
are wine and sulphuric acid. We’ve always had wine and 
sulphuric acid was synthesised by the Assyrians as early as 
the 7th century BC. It is, therefore, conceivable that ether was 
available to ancient civilisations.
In modern times, in Europe, the Swiss physician-alchemist, 
Paracelsus, observed the narcotic effects of ether in chickens. 
He  noted  that  they  “undergo  prolonged  sleep  and  awake 
unharmed”. Unfortunately, Paracelsus failed to grasp ether’s 
potential.  
Inimical to the potential was the concept. Henry Hickman 
(1800-1830) was a young Shropshire GP (fig 4), who had 
graduated  from  Edinburgh  about  50  years  after  James 
MacDonnell. He had no knowledge of ether but in 1825 he 
suggested in a letter to a local newspaper that ‘suspended 
animation’ might be used as a means of reducing pain during 
surgery. He had developed a technique which involved asking 
the patient to re-breathe from a bag. Taken to extremes re-
breathing will produce narcosis and this was the basis for 
Hickman’s suggestion, although of course he didn’t know the 
physiological basis for it. Needless to say, his results were not 
entirely satisfactory and he was roundly denounced in a letter 
to the Lancet in September 1826, under the caption ‘Surgical 
Humbug’1.  Hickman’s  patients  were  described  as  being 
‘doomed to come under his care’, that he was a disgrace to his 
profession, dishonourable, and a ‘quack’. The correspondent 
signed himself off, not entirely honourably, as ‘Antiquack’.  
Crawford Long (1815-1878) was an American GP practicing 
in Jefferson, then a remote outpost in the southern state of 
Georgia. Long is now credited as being the first doctor to 
administer ether as a general anaesthetic to a patient for a 
surgical operation. It took place in 1842. Had he announced 
his initial case report in the literature, he might now be hailed 
as the discoverer of anaesthesia. On the other hand he might 
have attracted a torrent of abuse like Hickman, and shortened 
his life. For whatever reason, Dr Long left the first public 
demonstration of ether anaesthesia to others. 
The first successful public demonstration of ether anaesthesia 
took place on 16th October 1846 in what has come to be 
known  as  the  ‘Ether  Dome’  in  the  Bulfinch  Building  of 
the Massachusetts General Hospital in Boston (fig 5). The 
following is a paraphrased account of what took place:
On Oct. 16, 1846, in the operating theater on the top floor 
of the building, one of the greatest moments in medicine 
occurred., William Morton, a Boston dentist, demonstrated 
the use of ether during surgery, ending the indescribable pain 
— and the overwhelming dread — that had been associated 
with the surgeon’s knife. 
Using a specially designed glass inhaler containing an ether-
soaked sponge, Morton, administered the anesthetic to Gilbert 
Abbott, a printer who had come to the MGH for removal of a 
vascular tumor on his jaw. After several minutes, Abbott was 
Fig 4. Henry Hickman
Fig 5. Mass. General Ether Dome© The Ulster Medical Society, 2009.
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rendered unconscious. John Collins Warren one of the most 
widely respected surgeons of that time, removed the tumor. 
Upon wakening, Abbott informed the curious and skeptical 
physicians and medical students in the theater that he had 
experienced no pain. 
As the patient was carried from the operating theatre, Warren 
turned and faced the incredulous onlookers, remarking as he 
did so,  “Gentlemen, this is no humbug,” a suitable riposte to 
the scurrilous Surgical Humbug letter penned some 20 years 
earlier by Antiquack. News of the discovery spread quickly, 
and within days it was hailed in the popular press as the 
“greatest gift ever made to suffering humanity.”  In the case 
of ether anaesthesia, the species jump from chicken to man 
had taken 300 years. 
The first recorded use of ether in Belfast was on 21st January 
1847  for  the  amputation  of  the  arm  of  a  young  woman. 
The next day the Belfast Newsletter published a detailed 
description of the proceedings in which it was stated that ‘her 
only intelligence of the operation was being sawn through’. 
The ether was probably administered by Dr Horatio Stewart 
for surgeon Alexander Gordon who later became the first 
Professor of Surgery at The Queen’s University2.
Although ether may have been, in John MacDonnell’s words, 
‘the greatest gift ever made to suffering humanity’ it was 
difficult to use well. (fig 6). Stewart and Gordon would have 
been feeling their way, trying as best they could to avoid 
cyanosis without the aid of oxygen or any knowledge at all 
as to how to maintain a patent airway, or avoid aspiration. 
These early ether anaesthetics must have been sporting affairs 
to say the least and no doubt some patients succumbed. One 
surgeon, Syme, in Edinburgh said of ether: ‘It will not do’, 
preferring to do his amputations without it. His patients, had 
he asked them, might have taken a different view. 
By  way  of  a  summary,  within  10  weeks  of  the  Boston 
demonstration, ether was being used London in UCL, surgeon 
Robert  Liston  remarking  that  ‘this Yankee  Dodge  beats 
mesmerism hollow’. Within a month of this, ether had reached 
Dublin, Edinburgh and Belfast. The world’s first chloroform 
anaesthetic was to follow towards the end of 1847.
James ‘Young’ Simpson (fig 7), an Edinburgh man, entered 
the University at the age of 14 years, and graduated MD in 
1832 at the age of 21 years. Seven years later he became 
Professor of Midwifery at Edinburgh University, a post he 
held for over 30 years. Hence he was nicknamed ‘young’ as 
in ‘young Simpson’. So ubiquitous did this usage become 
that he incorporated ‘Young’ into his name. Simpson’s many 
notable achievements in obstetrics were to be overshadowed 
by his discovery of the anaesthetic properties of chloroform. 
Like surgeon Syme, Simpson was dissatisfied with ether, a 
drug he had used in obstetrics, and sought a more pleasant 
and more rapidly acting anaesthetic. David Waldie, a medical 
man and an apothecary, suggested chloroform and Simpson 
and his friends inhaled this at a dinner party in Simpson’s 
house on 4th November 1847. (Just how such a party would be 
viewed by professional regulators these days is hardly a matter 
for  conjecture).  Not  surprisingly  all  became  unconscious 
and awoke delighted at their success. Within weeks Simpson 
published in the Lancet. 
Fig 6. Early chronology of Ether and chloroform
Fig 7. James Young Simpson
Fig 8. The Lavoisiers© The Ulster Medical Society, 2009.
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It is well known that Simpson was attacked for advocating 
general anaesthesia to relieve pain in childbirth. The Old 
Testament injunction that ‘in sorrow shalt thou bring forth’ 
was as strongly advocated as it was merciless. It was not until 
John Snow administered chloroform to Queen Victoria for 
the birth of Prince Leopold that anaesthesia for this purpose 
was accepted by the church. As Monarch she was Supreme 
Governor  of  the  Church  of  England  so  the  bishops  were 
left with little option. Simpson was the first person to be 
knighted for services to Medicine and be became one of the 
most famous doctors of his day, much loved by patients and 
colleagues alike. At his death funding for a new maternity 
hospital,  the  Simpson  Memorial  Maternity  Pavilion,  was 
raised by public subscription.  
In the latter years of the 18th century France was heading 
for Revolution.  It was indeed the best of times and the worst 
of times. It was a time of change on many fronts in ‘natural 
philosophy’ and for those interested in the chemistry of gases 
in particular. Why do I show this beautiful painting by the 
incomparable Jacques-Louis David of Charles Lavoisier and 
his wife (fig 8) at a lecture like this? 
Charles Lavoisier was the first to reveal the true nature of 
oxygen, a gas beloved of anaesthetists. In experiments on 
guinea-pigs he showed that respiratory gas exchange was a 
combustion describing it ‘like a candle burning’.  In so-doing 
he blew away the phlogiston theory of oxygen so beloved 
of Priestley. Secondly, he was the first to use quantitative 
methods in chemistry; measurement is close to the hearts of 
all anaesthetists. Thirdly, he introduced the double-barrelled 
nomenclature we use to describe inorganic salts, e.g. sodium 
chloride,  sodium  bicarbonate.  Fourthly,  he  wrote  the  first 
chemistry book, an important book in itself and one which 
had an influence on an even greater scientist, Humphry Davy 
(fig 9). 
Sadly, as an aristocrat, Lavoisier found himself on the wrong 
side in the years that followed. Trumped up charges were 
levelled against him. As Robespierre put it at the tribunal. 
‘The Revolution has no need of chemists’. At his execution 
at the age of 51 years in 1794 one of his friends remarked: 
‘It took but a moment to cut off his head, but it may take 100 
years to produce another like it’. 
Well, as is so often the case, the French underestimated the 
Anglo-Saxons. At the time of Lavoisier’s execution, Humphry 
Davy (1778 – 1829) was 16 years of age and destined to 
become the greatest scientist of his day. Davy was a polymath. 
As a chemist he isolated, amongst other things, potassium, and 
a few days later, sodium: he was the first to show that all acids 
contained hydrogen; he postulated that chemical forces were 
fundamentally  electrical,  and  demonstrated  electromotive 
forces in a cell. Outside of science he was highly regarded 
as a poet, a friend of Wordsworth, and an archaeologist. He 
became famous in his own lifetime but now is remembered 
chiefly  for  two  things:  the  indispensable  miner’s  lamp, 
and discovery of the analgesic properties of nitrous oxide. 
Unaccountably, for as a young man he had been a surgical 
assistant, Davy failed to grasp the potential of nitrous oxide 
as a means of alleviating the pain of surgery. What an irony 
that at the very time the much maligned Dr Hickman, only 
50 or so miles away, was experimenting with carbon dioxide 
narcosis, Humphry was administering nitrous oxide to treat 
‘hysteria’ in his Medical Pneumatic Institution in Bristol.  
On 11th December 1844, Gardner Quincy Colton (1814-1898) 
an erstwhile medical student, administered nitrous oxide as 
a general anaesthetic for the removal of a tooth. The patient 
was a Connecticut dentist called Horace Wells (1815-1848) 
who, on waking up afterwards, proclaimed: ‘a new era in tooth 
pulling’. The experiment was performed at Wells’ suggestion, 
a fact which Colton was always careful to acknowledge.
A few weeks later in January 1845, at the Massachusetts 
General Hospital, Wells himself attempted to repeat Colton’s 
experiment. Unfortunately, the patient moved and then cried 
out and Wells became a subject of ridicule. It is not clear what 
went wrong, if they rushed, or if the patient held his breath, or 
the gas mixture was dilute. Whatever the reason, the failure 
affected Wells very deeply and although he continued as a 
dentist for a time, he became profoundly depressed and ended 
up taking his own life. Although Wells failed in one sense, 
he was the first person to submit to the only 19th century 
anaesthetic drug still in use in 2008. In that sense both he 
and  Colton  should  be  remembered  as  important  pioneers 
of  anaesthesia.  When  the  flamboyant  and  entrepreneurial 
Colton returned empty handed from the Californian Gold 
Rush, he set up dental ‘offices’ in many American cities. The 
photograph (fig 10) shows an example of one of these with 
the cylinder of nitrous oxide on a bench to the left. 
In 1867 Colton visited Paris to attend the First International 
Medical Congress. At that meeting he met a dentist, TW 
Evans.  Evans,  a  Philadelphian  émigré  was  by  1867  a 
fashionable  Parisian  practitioner  numbering  amongst  his 
patients  the  President  of  the  2nd  Republic  himself,  Louis 
Napoleon. Colton instructed Evans in the use of nitrous oxide 
Fig 9. Humphry Davy© The Ulster Medical Society, 2009.
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and soon after the Paris Congress, Evans travelled  to London 
where he, in turn, demonstrated nitrous oxide at the London 
Dental Hospital. 
Nitrous  oxide  quickly  found  a  place  in  obstetric  practice 
and the Russian, Stanislav Klikovitch in St. Petersburg, was 
amongst the first to advocate it for self-administration by 
women in labour. Klikowitch’s methods were taken up by 
an  eminent  obstetrician,  Paul  Zweifel  in  Leipzig,  and  by 
one of his juniors, Albert Doderlein. Doderlein saw the need 
for some form of monitoring and was the first to measure 
blood  pressure  during  administration.  He  also  recognised 
the potential for hypoxia and checked the oxygen content 
of whole blood using a new spectrometric method recently 
developed by Felix Hoppe-Seyler (1885). 
Doderlein’s prescience was well judged as the risk of hypoxia 
has  always  been  a  major  concern  during  nitrous  oxide 
administration. It was not until the 1930s that machines were 
constructed which were capable of giving fixed percentages 
of nitrous oxide in air to women in labour. Ralph Minnitt of 
Liverpool gave his name to the most widely known of these. 
Another  was  named  after  Lucy  Baldwin,  later  Countess 
Baldwin of Bewdley, wife of British Prime Minister, Stanley 
Baldwin (fig 11a,b). She was a forceful advocate for pain 
relief in labour in the 1930s, possibly not unconnected with 
the fact that she gave birth to six children.
I have digressed. Important as obstetric analgesia was and 
is, it is only a small part of anaesthesia. So we will return to 
the 1850s to see something of how anaesthesia developed as 
a specialty. 
John Snow (1813-1858) of Broad Street pump fame (fig 12), 
was the first professional anaesthetist in these islands and 
was a powerful advocate of the physician anaesthetist. He 
was the first to apply scientific method to the administration 
of volatile drugs. He calculated dosages and kept detailed 
records of all his cases. Most remarkably he established that 
the potency of an inhaled anaesthetic is inversely related to 
its solubility in the blood. The opposite of what, at first sight, 
might be expected.  
Following  Snow’s  early  death  at  the  age  of  45  years, 
leadership  of  the  embryonic  specialty  in  England  fell  to 
another remarkable man. Joseph Clover (1825-1882) was an 
innovator par excellence who would find the straightjacket of 
modern research governance incomprehensible (fig 13). He 
experimented with combinations of nitrous oxide/ether in air 
and he designed many different types of breathing apparatus 
to facilitate this, including means by which concentrations 
could be adjusted. 
Here  he  is  inducing  anaesthesia  with  chloroform,  with  a 
finger on the patient’s pulse (fig 13). [When I started as an 
SHO in the main theatres in the Royal Victoria Hospital in 
1973, palpation of the pulse, careful observation of colour and 
temperature, and a sphygmomanometer were the only forms 
of monitoring available for routine surgery. ECG monitors 
Fig 10. A Colton dental office
Fig 12. John Snow
Fig 11. The Minnitt (left) and the Lucy Baldwin (right) apparatus© The Ulster Medical Society, 2009.
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(single  lead)  were  rare,  unreliable  and  highly  susceptible 
to diathermy interference]. In the photograph he is using 
his  famous  inhaler  which  remained  in  use,  in  its  various 
modifications, right up to the Second World War. 
During the 100 years from 1850 to the mid 1950s, ether and 
chloroform  were  the  only  volatile  anaesthetics  in  general 
use. Of the two, ether was the more widely used, because 
it was relatively safe and, by the standards of the time, its 
administration could be entrusted to young doctors, medical 
students or even nurses. 
In  contrast,  chloroform  was  intrinsically  hazardous.  It 
induced dangerous cardiac arrhythmias and was associated 
with fulminant liver failure. However, it provided excellent 
anaesthesia  and  was  certainly  preferred  in  Scotland  and 
Ireland. It was never popular in USA probably because of a 
shortage of doctors; the administration of chloroform could 
not be entrusted to medical students and nurses. 
Despite the higher risk of death with chloroform (estimated at 
1 in 4,500 compared to 1 in 21,000 with ether) its popularity 
soared in the UK and in many other European countries. 
Such a situation could not be allowed to continue and the 
Hyderabad  Commission  1890  concluded  that  it  caused 
hypoxia. This was the beginning of the end for chloroform. 
It was the correct result but for entirely the wrong reasons. 
You may have noticed that I’ve drifted across the Atlantic 
Ocean – the last American I mentioned was the ‘American 
Dentist’ who brought the good news from Paris to the London 
Dental Hospital.  The fact is that during all of this time, not 
only did Britain rule the waves, but British anaesthesia ruled 
as well. Its pre-eminence up to the beginning of World War 
II was largely the result of the efforts of three men, Snow, 
Clover and Frederick Hewitt. Writing of them, the late Rod 
Calverley of University of California had no doubt that they 
were exceptional. Not only was that indeed the case, but 
British anaesthesia, indeed British surgery too, was fortunate 
that the professional lives of these three overlapped in such a 
way as to provide continuity. 
It is not generally known that Clover (who died in 1882) 
was the first to perform an emergency cricothyroidotomy. 
He  averted  disaster  by  inserting  a  curved  cannula  of  his 
own design through the cricothyroid membrane, thereby by-
passing a large oral tumour. He remarked afterwards that ‘I 
never used it before although it has been my companion at 
some thousands of cases’. That was Clover, obsessed with 
patient safety, and unusually for his time, well prepared for 
trouble. Frederick Hewitt was a man of like mind. 
The successor to Snow and Clover, Hewitt (1857 – 1916) was 
the leading English anaesthetist of his day and an outstanding 
clinician (fig 14). We might remember him for a dozen things. 
He perfected Clover’s portable inhalers, and most importantly 
invented  the  first  apparatus  capable  of  delivering  oxygen 
and nitrous oxide in variable proportions.  Apart from his 
clinical contributions Hewitt should be remembered for his 
contributions to anaesthetic training and education. It was on 
Fig 13. Clover – hand on pulse
Fig 14. Sir Frederick Hewitt© The Ulster Medical Society, 2009.
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his insistence that anaesthesia became part of the curriculum 
in all British medical schools. In 1893 he wrote the first 
anaesthetic textbook, a book which subsequently ran to five 
editions. 
Hewitt was the first anaesthetist to be knighted, possibly on 
account of his ministrations to the future King Edward VII 
whom he anaesthetised for a perforated appendix on the eve 
of his planned Coronation.  The future King, and here he is 
in his Coronation robes (fig 15), was not an ideal anaesthetic 
subject, being obese, bearded and much given to tobacco and 
strong drink. Most of us today would baulk at anaesthetising 
him. To do it with open-drop ether without any form of airway 
protection would have been a considerable challenge, even for 
a clinician of Hewitt’s skill. 
The subsequent reigns of Edward VII and his son George V 
saw great upheavals in the world and everything was caught 
up in them. The years from 1914 - 1934 saw advances in 
anaesthetic equipment, notably Henry Boyle’s machine and 
the arrival of Ulsterman, Sir Ivan Magill’s tracheal tube. But 
why 1934?  To understand that we must go back to another 
era,  to  another  starting  point,  a  starting  point  which  was 
central to the evolution of modern anaesthesia.
Sir  Christopher  Wren’s  Royal  Chelsea  Hospital  was 
completed in 1692 and is still in use for the purpose for which 
it was built. With its magnificent chapel, it stands in stark 
contrast to the inhuman designs of modern hospitals (fig 16). 
Wren gave patients, their relatives and the staff something 
to  lift  their  spirits,  perhaps  even  their  souls. The  earliest 
intravenous administrations of substances were performed in 
the neighbourhood of Oxford around 1656 and were attributed 
to Wren. What a polymath he was! Robert Hooke said of him:
‘Since  the  time  of Archimedes  there  scarce  ever  met  in 
Fig 16. The Royal Chelsea Hospital chapel
Fig 17. Intravenous ‘anaesthetics’ Fig 15. King Edward VII © The Ulster Medical Society, 2009.
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one  man  so  great  perfection,  such  mechanical  hand  and 
philosophic mind’. 
He injected opium and other substances into dogs to see if 
substances could be given directly into the circulation and still 
exert their characteristic effects. If they did it would explain 
the rapid collapse following bites by venomous snakes. 
Henry Oldenburg, a civil servant associate who was present 
at the time recorded:
‘he thought he could easily contrive a way to conveigh any 
liquid thing to the blood by making ligatures on the veins…
and putting into them slender syringes...fastened to bladders 
containing the matter to be injected’. 
Oldenburg went on to say that they used ‘big, lean dogges 
that the vessels might be large enough and easily accessible’. 
Given opium in this way the dogs were temporarily stupefied, 
but they survived, though probably not for long.  
What excitement there must have been in the minds of Wren, 
Harvey, Hooke, Willis and others, as they began to uncloak 
these secrets right at the beginning of the scientific age.  Those 
who wish to read more can find refer to Norman Bergman’s 
paper3 or enjoy Iain Pears’ very well researched historical 
novel, ‘An Instance of the Fingerpost’4. 
Many circumstances had to change before intravenous drug 
administration could become a reality, including the concept 
of aseptic technique. An early hypodermic syringe, dating 
from  1860  and  described  as  English,  can  be  seen  in  the 
Science Museum in London. It was designed by an Irish 
physician (Francis Rynd) and made in Dublin by an Austrian 
silversmith. Rynd had already invented the hollow needle in 
1844. 
Dr  Alexander  Wood  was  the  first  physician  to  use  a 
hypodermic syringe to inject narcotic drugs into a patient.  In 
1853 he injected morphine into ‘painful points’ and published 
a report in the Edinburgh Medical and Surgical Journal. So far 
as we know he did not inject morphine intravenously (fig 17). 
Intravenous  anaesthesia  was  very  slow  to  establish  itself, 
partly due to the absence of suitable drugs, partly due to the 
difficulty of preventing sepsis. The arrival of barbiturates 
in the 1930s revolutionised anaesthesia. For the first time 
there  was  a  drug  which  could  induce  anaesthesia  in  one 
arm-brain circulation time – normally around ten seconds. 
Hexobarbitone  was  the  first  of  these  drugs  to  achieve 
popularity and in the twelve years following its introduction 
it was used to anaesthetise approximately 10 million patients. 
However, the barbiturate which would be the gold standard 
for the next 60 years or so, was yet to come.
This is a record of the first administration of thiopentone 
(Pentothal). It took place on 8th March 1934 at the University 
of Wisconsin Hospital and the anaesthetist was Dr Ralph 
Waters (fig 18a,b). He was another exceptionally gifted doctor 
and went on to become the world’s first University Professor 
of Anaesthesia. Waters was a strong believer in the concept 
of  research-led  teaching  and  did  much  to  encourage  the 
development of academic anaesthesia in Britain. It is notable 
that a man of Waters’ stature could, almost 80 years after the 
death of John Snow, write this about that great man:
‘He is my idol, the more I try to do various things, the more 
respect I have for him. We need not hesitate to say that John 
Snow was and remains the greatest anaesthetist as well as 
the first’.
The use of ether to induce anaesthesia declined rapidly after 
1934 and thiopentone was soon the standard method. Of 
course, ether, and if you were brave, chloroform, remained 
the only means of maintaining general anaesthesia. 
The  next  great  advance  in  anaesthesia  originated  in  the 
jungles of Ecuador. The first medical uses of curare were 
Fig 18. Reproduction (left) of the anaesthetic record of 
the first administration of Thiopentone, 8th March 1934 by 
Ralph Waters (right)
Fig 19. Harold Griffith© The Ulster Medical Society, 2009.
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for relieving muscular spasms due to disease, or the spasms 
induced by EEG in psychiatric patients. Drs Manny Papper 
and Stuart Cullen were the first to use curare in anaesthesia. 
They gave it to two patients in Bellevue Hospital, New York 
City, in 1941. After the operation they were horrified to be 
confronted by two patients who could not breathe, and who 
had to be resuscitated overnight. Apnoea was not regarded 
as lightly then as it is now, and the concept of reversal was 
some way off. Papper, who later became the 
first anaesthesiologist Dean of an American 
Medical School was so shocked by the whole 
experience that he went so far as to say that 
curare had no place in anaesthesia. 
Papper  may  have  thought  curare  had  no 
place  in  anaesthesia,  but  Harold  Griffith  in 
Montreal  was  confident  that  he  could  deal 
with respiratory paralysis if it occurred (fig 
19).  In  July  1942,  Griffith  and  Johnston 
reported the successful use of curare in a series 
of  25  cases  performed  in  the  Homeopathic 
Hospital,  Montreal5.  This  series  marked  a 
second  revolution  in  anaesthetic  practice. 
Combined  with  tracheal  intubation,  which 
it  facilitated,  curare  transformed  surgical 
operating conditions. 
The third revolution, had to wait for the Second World War 
and the Manhattan Project. In order to generate sufficient 
quantities of fissionable uranium for the atom bomb, Ur238 had 
to be enriched using uranium hexafluoride. The researches in 
fluorine chemistry which were necessary to bring this about 
were the springboard which gave rise to our modern heavily 
fluorinated anaesthetic drugs.
Halothane was first synthesised in 1951 in the laboratories of 
ICI by Charles Suckling. He began by asking anaesthetists 
what they wanted and it is a measure of his knowledge of 
organic  fluorines  that  halothane  was  one  of  the  first  six 
anaesthetic  compounds  he  synthesised.  Halothane  was 
revolutionary in being non-flammable, non-irritant, and much 
more potent than ether. Initial studies confirmed that it was 
rapidly acting with rapid recovery characteristics.    
Revolutionary as it was, halothane was not perfect. Being 
similar to chloroform structurally, it had similar side-effects 
although  generally  these  were  much  less  pronounced. 
Fulminant liver failure on repeat administrations, although 
rare, became a growing concern in the 1970s, and a quest 
for better alternatives gained pace. Ross Terrell synthesised 
over 700 fluorinated ethers, of which just three, enflurane, 
isoflurane  and  desflurane  became  available  for  routine 
practice. Of these three only isoflurane and desflurane remain 
in  regular  use  today. Terrell  remains  largely  unknown  to 
the general public despite the great service he rendered to 
mankind.  
Sevoflurane  was  not  one  of  Ross Terrell’s  ethers.  It  was 
discovered in the 1960s, not long after halothane, and was 
initially promoted in Japan. For regulatory reasons it was 
not licensed in the UK until 1995. Its properties are close to 
ideal although it has been associated with toxic degradation 
products when used in closed circuits with standard soda lime. 
This possible disadvantage can be circumvented by using 
carbon dioxide absorbents which do not contain strong alkalis. 
Sevoflurane has become the standard volatile agent for most 
purposes in the UK and much of Western Europe. 
The question now is, has anaesthesia reached such a state of 
perfection that nothing more remains to be done? I do not 
think so. Whilst time does not permit me to delve into local 
anaesthetics, or the newer generations of opiates, non-opiate 
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analgesics, muscle relaxants or relaxant reversal drugs, the 
fact remains that we are still heavily reliant on opiates, with 
all their pharmacological baggage, to control severe pain. 
Our understanding of pain mechanisms, and of anaesthesia 
itself remains superficial. Our ability to control postoperative 
emetic symptoms is often ineffective and whilst we can keep 
people alive in intensive care units, we often lack any depth 
of understanding of the therapies we apply. Worse still, and 
surely the most serious gap in our knowledge, is that we 
cannot tell for sure if our patients are anaesthetised or not. We 
perform certain manoeuvres which we know from experience 
will in most cases result in an anaesthetic state, but we do not 
have a reliable, quantitative measure of ‘depth’ or even an 
adequate definition of what is meant by the term.
A  large  prospective  trial  of  over  11,000  adult  patients 
reported in the Lancet eight years ago quoted a figure for 
explicit awareness of 1 in 1000 overall, but almost twice this 
when muscle relaxants were used6. This year, an alarmingly 
high incidence of 1 in 100 was reported in a very carefully 
performed  study  of  4001  adult  patients  in  the  University 
Hospital  in Valencia7. This  group  excluded  patients  most 
at risk so even this high figure may underestimate the true 
incidence. A prospective study of 184 children aged 5 -18 
years this year revealed no explicit recall but two children 
responded  positively  under  the  modified  isolated  forearm 
technique, an incidence of around 1 in 1008. 
The  risk  factors  are  well  known  and  include:  caesarean 
section,  absence  of  benzodiazepine  premedication, 
emergencies, young patients, cardiac surgery and difficult 
intubation.  The  consequences  include  nightmares,  post 
traumatic  stress,  depression,  anxiety  and  flashbacks.  One 
third of the patients in the Valencia study experienced one or 
more of these. 
Can anything be done? At present the adequacy of anaesthesia 
is either deduced from end-tidal concentration values in the 
case of volatile anaesthesia, or indirectly from algorithms 
used to calculate target infusion dosage in the case of total 
intravenous techniques.  
The bispectral index (BIS) monitor (fig 20) displays a real-
time electroencephalography (EEG) trace, sampled from the 
fronto-temporal area. It generates a dimensionless number 
with 100 representing normal activity.  Studies have shown 
that the probability of awareness is very low when the BIS 
is kept <60 intraoperatively but there are serious problems 
in applying this universally. Firstly, there is no gold-standard 
against  which  the  bispectral  index  can  be  measured  and 
judged. Secondly, there is marked patient variability. Thirdly, 
there is no clear-cut transition value which can be used to 
differentiate between sleep and awake. Finally, our current 
knowledge  of  the  primary  sites  of  action  of  anaesthetics 
suggests  that  these  are  distant  from  the  fronto-temporal 
cortex. 
Furthermore, there is no agreement on the value of BIS as a 
means of reducing anaesthetic awareness. A Cochrane Review 
last year9 reported that when intravenous or volatile-based 
anaesthesia was guided by bispectral index monitoring, there 
was less awareness, and there were significant improvements 
in the quality of the anaesthetic overall.  In contrast, a more 
recent US study reporting a comparison of bispectral and 
end-tidal agent monitoring concluded that BIS monitoring 
conferred no advantage10. Nor could the Cochrane review 
have examined a recent Australian study11. This showed that 
during  anaesthesia,  the  EEG  in  infants  is  fundamentally 
different  from  the  EEG  in  older  children.  The  authors 
concluded that we lacked the necessary information to allow 
us to use anaesthetic depth monitors in infants. 
So, I come back to the original question. What, if anything, 
can be done? 
The problem for anaesthetists is that if we adopt protocol-
driven methods based on bispectral indices, then in order 
to  keep  the  monitor  reading  where  it  should  be,  we  will 
inevitably administer higher concentrations of potent drugs 
than are necessary, or safe, for some patients. We do not have 
data  which  would  allow  us  to  develop  patient-specific  or 
condition-specific protocols. These we need. 
In  a  recent  editorial,  Beverly  Orser,  from  the  University 
of Toronto, spelled out the obstacles to a reliable depth of 
anaesthesia  monitor12.  Anaesthetics  have  complex  actions 
involving memory, pain, consciousness, vascular autonomic 
responses, etc. These responses require specific drugs for 
their suppression and the doses used are often very critical. 
Orser warns of the dangers of handing over critical elements 
of patient care to a ‘black box’ and concluded that we won’t 
get anywhere until we knew a lot more about how and where 
anaesthetics work.
Although our knowledge of the mechanism of anaesthesia is 
sketchy it is advancing rapidly13. For example, we know with 
certainty that the β3 subunit of the GABAA receptor mediates 
both volatile and intravenous anaesthesia.  
By creating mutations in the beta sub unit, we can produce 
mice which are resistant to specific anaesthetics. Figure 21 
represents a beta subunit of a GABAA receptor. The N265 
mutation shown here renders an affected mouse completely 
resistant to propofol, a modern day thiopentone (Pentothal). 
This particular mutation had no effect on other intravenous 
anaesthetics.
Second, we are reasonably sure that the thalamus and its 
Fig 22. Thalamic projections. Reproduced by permission from 
Macmillan Publishers Ltd NRN (from reference 13).  
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projections (fig 22) are important in the anaesthetic state. 
The neuronal pathways within the pink shaded oval are all 
GABA-ergic and are more active during sleep. We know 
that the ventrolateral preoptic nucleus (VLPO) is activated 
by anaesthesia and we hypothesise that it in turn activates 
sleep promoting pathways to the basal forebrain and anterior 
hypothalamus.
Thirdly, from PET studies it would seem that anaesthesia 
resembles  normal  sleep.  As  in  normal  sleep  the  largest 
decreases  in  blood  flow  during  anaesthesia  are  in  the 
thalamus, brainstem and basal ganglia. The precuneus appears 
to be involved in a range of highly complex tasks, including 
the  monitoring  of  the  world  around  us.  It  is  profoundly 
de-activated  both  in  deep  sleep  and  anaesthetic-induced 
unconsciousness. 
As I come to the end of the lecture and look forward, it is 
hard to know if doctors of my generation are labouring in the 
twilight of a golden age of medical practice, or witnessing 
some new dawn. There are many dark clouds including the 
likelihood of economic decline in the next 50 years, climate 
change and burgeoning population growth. The profession 
itself will be challenged by part-time practice, increasing 
patient expectations and ever more intrusive regulation and 
control.
What  will  be  the  consequences  of  the  current  decline  in 
traditional research-led education and training of medical 
students? What a tragedy it is that the intellectual freedoms 
which  in  the  past  have  delivered  so  much  are  now  so 
undervalued. How regrettable it is that the freedoms which 
allowed  generations  of  my  clinical  colleagues  to  conduct 
small research projects on the basis of a clinical observation, 
or  even  a  hunch,  have  effectively  been  lost.  It  is  worth 
remembering that it was those very freedoms which gave us 
modern anaesthesia, not million pound research grants or 
research strategies. 
We have travelled a long way from the clouds of vapour and 
gas which first induced a state of unknowing in 1846. I’ve 
mentioned our lack of knowing as we struggled to find safe 
drugs, and good methods of administration. I’ve referred to 
our ignorance when it comes to patient awareness and the 
mechanisms of anaesthesia. I’ve alluded to storm clouds on 
the horizon. But I would like to end on a positive note, not 
just because it is a better way to end, but because I believe that 
there is always the potential for good, no matter how trying 
the circumstances. 
And as this child struggles, in very trying circumstances, 
against the choking cloud of ether the words of the English 
poet clergyman, William Cowper, would seem to resonate, for 
her, and for us: (fig 23)
Ye fearful Saints, fresh Courage take 
The Clouds ye so much Dread 
Are Big with mercy, and shall Break 
In Blessings on your Head.
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